Tixagevimab (anti-Spike RBD)

CAS: 2420564-02-7 货号: Ab209842
有货
级别和纯度: 无动物源 ? 无动物源(Animal Free)—— 不含动物源成分生产,降低污染风险。适用于避免动物源材料的生物制造和培养。 无载体 ? 无载体(Carrier Free)—— 不含添加的载体蛋白/稳定剂。当载体(如 BSA)会干扰偶联或敏感检测时使用。 重组 ? 重组(Recombinant)—— 通过重组表达生产,序列确定、批次稳定。适用于来源明确、无动物源的可重现蛋白。 ExactAb™ ? ExactAb™ —— 阿拉丁强调精准和验证质量的抗体系列。适用于可靠、特异性经验证的抗体应用。 低内毒素 ? 低内毒素级 —— 内毒素降至受控低水平。适用于高内毒素会造成干扰的敏感生物工作。 无叠氮钠 ? 无叠氮(Azide Free)—— 不含叠氮化钠防腐剂。适用于叠氮有毒或有抑制作用的偶联、细胞工作或检测。 已验证 ? 已验证级 —— 发布前在特定应用中确认性能。当需要试剂按声称工作的书面保证时使用。 ≥95%(SDS-PAGE&SEC-HPLC) 见COA
应用
Animal Model, ELISA, Flow Cytometry, Functional Assay
宿主种属
人(Human)
种属反应性
严重急性呼吸系统综合征冠状病毒2型(SARS-CoV-2)
亚型
Human IgG1
偶联
Unconjugated
★
规格
库存
价格
数量
100μg
Ab209842-100μg
现货 Stock Image
¥389.90
1mg
Ab209842-1mg
现货 Stock Image
¥1,949.90
5mg
Ab209842-5mg
现货 Stock Image
¥5,002.40
10mg
Ab209842-10mg
期货 Stock Image
¥10,699.90
请输入您要添加的产品数量
🧪
为什么选择此级别

ExactAb™,低内毒素,已验证,无动物源,无叠氮钠,无载体,重组 级 提供 ≥95%(SDS-PAGE&SEC-HPLC) 纯度,适用于对基线干扰要求严格的色谱和分析工作流程。

🌡

储存与运输

-80℃储存,避免反复冻融。特低温运输 。请查阅批次 COA 获取详细规格。

📋

质量文档

SDS、COA、产品数据表及规格说明书均可下载。可通过批号查询获取批次 COA。

📚

文献证明

在色谱分析、有机合成和交叉偶联反应领域已被 0 篇同行评审文献引用。

概述

Tixagevimab (anti-Spike RBD) 是一种人源单克隆抗体, 可以靶向SARS-CoV-2 受体结合结构域(RBD)。通过与 RBD 和 S 糖蛋白外域结合,并阻断 S 糖蛋白介导的与受体的结合而表现出对 SARS-CoV-2 的中和活性。

Tixagevimab (anti-Spike RBD) is a human monoclonal antibody that targets the SARS-CoV-2 receptor binding domain (RBD). It exhibits neutralizing activity against SARS-CoV-2 by binding to the RBD and the S-glycoprotein ectodomain and blocking S-glycoprotein-mediated binding to the receptor.

规格

产品名称
Tixagevimab (anti-Spike RBD)
别名
替沙格韦单抗 | Spike RBD抗体 | Spike RBD单克隆抗体 | SARS-CoV-2药靶抗体 | SARS-CoV-2单克隆抗体 | SARS-CoV-2抗体 | Spike RBD药靶抗体
英文别名
Spike RBD antibody | Anti-Spike RBD antibody | Anti-Human Spike RBD Recombinant Antibody | Anti-Spike RBD Reference Antibody | SARS-CoV-2 antibody | Anti-SARS-CoV-2 antibody | AZD8895
规格或纯度
无载体, 重组, ExactAb™, 低内毒素, 无叠氮钠, 已验证, 无动物源, ≥95%(SDS-PAGE&SEC-HPLC), 见COA
宿主种属
人(Human)
特异性
Spike RBD
种属反应性
严重急性呼吸系统综合征冠状病毒2型(SARS-CoV-2)
偶联
Unconjugated
克隆类型
重组抗体
Format
Whole IgG
轻链亚型
kappa
纯化方法
Protein A purified
浓度
见COA
CAS编号和信息
2420564-02-7
分子类型
抗体
产品线
生物产品
储存与运输
储存缓冲液
Supplied as a 0.22μm filtered solution in 100mM Pro-Ac, 20mM Arg, pH 5.0
防腐剂
No
储存条件
-80℃储存,避免反复冻融
运输条件
特低温运输
稳定性与储存
Store at -80℃ for 24 months. Upon receipt, it is recommended to aliquot. Avoid freeze/thaw cycle.
图片

Tixagevimab (anti-Spike RBD) (Ab209842) - ELISA
Immobilized Recombinant Human Spike RBD (rp155929) protein at 1.0 μg/mL can bind Tixagevimab (anti-Spike RBD) (Ab209842) with the EC50 of 10.69 ng/mL.

Tixagevimab (anti-Spike RBD) (Ab209842) - SEC
The purity of Tixagevimab (anti-Spike RBD) (Ab209842) is more than 95% verified by HPLC.

技术文档

📋 安全数据表 (SDS)

全面的危险、操作、储存及法规合规文件。

下载 SDS →

✅ 分析证书 (COA)

批次质量数据。输入批号以获取对应 COA。

查询 COA →

📊 产品数据表

产品规格和应用的快速参考摘要。

查看数据表 →

🔬 规格说明书

该级别的完整质量属性和验收标准。

查看规格说明 →

高级数据

质检证书(CoA,COO,BSE/TSE 和分析图谱)
C of A & Other Certificates(BSE/TSE, COO):
输入批号以搜索分析图谱:

通过匹配包装上的批号来查找并下载产品的 COA,每批产品都进行了严格的验证,您可放心使用!

找到3个结果

批号(Lot Number) 证书类型 货号
ZJ25F0117156 分析证书 Ab209842
ZJ25F0117155 分析证书 Ab209842
ZJ25F0117157 分析证书 Ab209842
溶液计算器

相关产品

Goat Anti-Human IgG H&L (HRP)-19553,用于WB,ELISA,IHC各种应用
Mouse Anti-Human IgG Antibody-19553,用于ELISA,CLIA各种应用
Mouse Anti-Human IgG H&L (HRP)-19553,用于ELISA各种应用
Mouse Anti-Human IgM Antibody-19553,用于ELISA各种应用
Human IgG-19554,用于WB,CLIA,LF,EIA,PRTIA各种应用,>95%
Goat Anti-Human IgG Antibody-19553,用于ELISA,CLIA,LFAs,WB and other immunoassay methods各种应用,≥ 95%
Bebtelovimab (anti-Spike RBD)-19552,穗状糖蛋白抑制剂
Mouse Anti-Human IgA H&L Antibody-19553
Goat Anti-Human IgG (HRP)-19553
Goat Anti-Human IgG (Biotin)-19553
Goat Anti-Human IgG (APC)-19553
Goat Anti-Human IgG (Cy5)-19553
Goat Anti-Human IgG (TRITC)-19553
Goat Anti-Human IgG (PE)-19553
Goat Anti-Human IgG (FITC)-19553
Mouse Anti-Human IgE epsilon chain Antibody-19553
Goat Anti-Human IgG Fc Antibody-19553
Regdanvimab (anti-Spike RBD)-19552,>95% (SDS-PAGE&SEC),穗状糖蛋白抑制剂
Casirivimab (anti-Spike RBD)-19552,>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg,穗状糖蛋白抑制剂
Bamlanivimab (anti-Spike RBD)-19552,>95% (SDS-PAGE&SEC),穗状糖蛋白抑制剂
Sotrovimab (anti-Spike RBD)-19552,>95% (SDS-PAGE&SEC),穗状糖蛋白抑制剂
Etesevimab (anti-Spike RBD)-19552,>95% (SDS-PAGE&SEC); Endotoxin Level<1.0EU/mg,穗状糖蛋白抑制剂
Imdevimab (anti-Spike RBD)-19552,>95% (SDS-PAGE&SEC),穗状糖蛋白抑制剂
Human IgG2-Kappa-19554
Human IgG3-kappa-19554
Cilgavimab (anti-Spike RBD)-19552
Mouse IgG2b-kappa, anti-Spike RBD-19554
Mouse IgG2a-kappa, anti-Spike RBD-19554
Rat IgG2a-kappa, anti-Spike RBD-19554
Human IgG1-kappa, anti-Spike RBD-19554
Human IgG4-kappa-19554
Goat Anti-Human IgG (AF647)-19553
Goat Anti-Human IgG (AF405)-19553
Human IgG (FITC)-19554
Human IgG (APC)-19554
Human IgG1(P331S/E430G)-kappa, anti-HEL-19554
Human IgG (PE)-19554
Human IgG1(D265A/N297A)-kappa, anti-HEL-19554
Human IgG1(K409R/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(P329G/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(F405L)-kappa, anti-HEL-19554
Human IgG1(N297Q)-kappa, anti-HEL-19554
Human IgG (Biotin)-19554
Human IgG1(N297S)-kappa, anti-HEL-19554
Human IgG1(E233A/L235A)-kappa, anti-HEL-19554
Human IgG1(K214R/N297A)-kappa, anti-HEL-19554
Human IgG1(K214R/L234A/L235A)-kappa, anti-HEL-19554
Human IgG1(N297A/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(L234F/L235E)-kappa, anti-HEL-19554
Human IgG1(D265A)-kappa, anti-HEL-19554
Human IgG1(K214R/L234F/L235E/P331S)-kappa, anti-HEL-19554
Human IgG1(K214R/E356D/M358L)-kappa, anti-HEL-19554
Human IgG1(L234A/L235A/G237A)-kappa, anti-HEL-19554
Human IgG1(L234A/L235A/F405L)-kappa, anti-HEL-19554
Human IgG1(D270N)-kappa, anti-HEL-19554
Human IgG4(S228P)-kappa, anti-HEL-19554
Human IgG1(N297A)-kappa, anti-HEL-19554
Human IgG4(S228P/L235E/P329G)-kappa, anti-HEL-19554
Human IgG1-lambda1, anti-Spike RBD-19554
Human IgG1-lambda2, anti-Spike RBD-19554
Rat IgG2b-kappa, anti-Spike RBD-19554
Rat IgG1-kappa-19554
Amubarvimab (anti-Spike RBD)-19552
Goat Anti-Human IgG (AF555)-19553
Human IgG1-kappa (AF647), anti-Spike RBD-19554
Human IgG1-kappa (AF405), anti-Spike RBD-19554
Human IgG1-kappa (APC), anti-Spike RBD-19554
Human IgG1-kappa (Biotin), anti-Spike RBD-19554
Human IgG1-kappa (AF700), anti-Spike RBD-19554
Human IgG1-kappa (FITC), anti-Spike RBD-19554
Mouse IgG2a-kappa (APC), anti-Spike RBD-19554
Mouse IgG2a-kappa (FITC), anti-Spike RBD-19554
Mouse IgG2a-kappa (AF700), anti-Spike RBD-19554
Mouse IgG2a-kappa (AF647), anti-Spike RBD-19554
Mouse IgG2a-kappa (AF555), anti-Spike RBD-19554
Mouse IgG2a-kappa (AF405), anti-Spike RBD-19554
Mouse IgG2a-kappa (Biotin), anti-Spike RBD-19554
Human IgG1-kappa (AF555), anti-Spike RBD-19554
Rat IgG2b-kappa (Biotin), anti-Spike RBD-19554
Rat IgG2b-kappa (APC), anti-Spike RBD-19554
Rat IgG2b-kappa (FITC), anti-Spike RBD-19554
Rat IgG2b-kappa (AF555), anti-Spike RBD-19554
Rat IgG2b-kappa (AF647), anti-Spike RBD-19554
Rat IgG2a-kappa (AF405), anti-Spike RBD-19554
Rat IgG2a-kappa (AF647), anti-Spike RBD-19554
Rat IgG2a-kappa (FITC), anti-Spike RBD-19554
Rat IgG2a-kappa (APC), anti-Spike RBD-19554
Rat IgG2b-kappa (AF700), anti-Spike RBD-19554
CR3022 (anti-Spike RBD)-19552
Rat IgG2b-kappa (AF405), anti-Spike RBD-19554
Rat IgG2a-kappa (AF700), anti-Spike RBD-19554
Centrose patent anti-dysadherin (anti-Dysadherin)-19552
Romlusevimab (anti-Spike RBD)-19552
Mouse IgG2b-kappa (Biotin), anti-Spike RBD-19554
Mouse IgG2b-kappa (FITC), anti-Spike RBD-19554
Mouse IgG2b-kappa (APC), anti-Spike RBD-19554
Mouse IgG2b-kappa (APC-Cy7), anti-Spike RBD-19554
Human IgG (AF647)-19554
Human IgG (AF488)-19554
Human IgG (AF700)-19554
Human IgG (AF405)-19554
Rat IgG2a-kappa (AF555), anti-Spike RBD-19554
Mouse IgG2b-kappa (AF555), anti-Spike RBD-19554
Goat Anti-Human IgG (AF488)-19553
Goat Anti-Human IgG Fc (Cy5)-19553
Goat Anti-Human IgG Fc (AF555)-19553
Goat Anti-Human IgG Fc (TRITC)-19553
Goat Anti-Human IgG Fc (AF700)-19553
Goat Anti-Human IgG Fc (AF405)-19553
Goat Anti-Human IgG Fc (Biotin)-19553
Goat Anti-Human IgG Fc (AF647)-19553
Goat Anti-Human IgG Fc (FITC)-19553
Human IgG (AF555)-19554